osteosarcoma

Open Access
Radiodynamic Therapy Using 5-Aminolevulinic Acid as a New Treatment Option for Osteosarcoma: An In Vitro and In Vivo Study
YUKI TANEMURA, TOMOKI NAKAMURA, YUMI MATSUYAMA, TOMOHITO HAGI, TAKAHIRO IINO and MASAHIRO HASEGAWA

Anticancer Research June 2026, 46 (6) 3091-3097; DOI: https://doi.org/10.21873/anticanres.18183
You have access
Potential of Inflammatory and Nutritional Markers and Clinicopathological Factors for Prognostic Prediction in Osteosarcoma
KAZUHIKO HASHIMOTO, SHUNIJI NISHIMURA and KOJI GOTO

Anticancer Research May 2026, 46 (5) 2713-2723; DOI: https://doi.org/10.21873/anticanres.18151
You have access
Amlodipine Suppresses Lung Metastasis by Increasing Cell Stiffness
TERUYA UCHIYAMA, KUNIHIRO ASANUMA, KOUJI KITA, TAKAYUKI OKAMOTO, EIJI KAWAMOTO, RYOHEI ADACHI, KENTA NAKATA, YUMI MATSUYAMA, TOMOHITO HAGI, TOMOKI NAKAMURA, MOTOMU SHIMAOKA and MASAHIRO HASEGAWA

Anticancer Research February 2026, 46 (2) 689-703; DOI: https://doi.org/10.21873/anticanres.17979
Open Access
P53-Armed Oncolytic Virotherapy Promotes the Efficacy of PD1 Blockade in Murine Osteosarcoma Tumors
MIHO KURE, HIROSHI TAZAWA, KOJI DEMIYA, HIROYA KONDO, YUSUKE MOCHIZUKI, TADASHI KOMATSUBARA, AKI YOSHIDA, KOJI UOTANI, JOE HASEI, TOMOHIRO FUJIWARA, TOSHIYUKI KUNISADA, YASUO URATA, SHUNSUKE KAGAWA, TOSHIFUMI OZAKI and TOSHIYOSHI FUJIWARA

Anticancer Research January 2026, 46 (1) 69-84; DOI: https://doi.org/10.21873/anticanres.17924
Open Access
Osteosarcoma of the Diaphysis: A Report from the Cooperative Osteosarcoma Study Group (COSS)
STEFAN S. BIELACK, CLAUDIA BLATTMANN, LEO KAGER, DANIEL BAUMHOER, ARNDT BORKHARDT, TOBIAS FEUCHTINGER, GODEHARD FRIEDEL, JENDRIK HARDES, SEMI BEN HARRABI, WOLF HASSENPFLUG, THEKLA VON KALLE, MATTHIAS KEVRIC, ANTONIA KNOLL, THOMAS KÜHNE, CLAUDIA ROSSIG, BENJAMIN SORG, MATHIAS WERNER, REINHARD WINDHAGER and STEFANIE HECKER-NOLTING

Anticancer Research November 2025, 45 (11) 5031-5043; DOI: https://doi.org/10.21873/anticanres.17844
You have access
Epidemiological Analysis of Malignant Bone and Cartilage Tumors in the Hand With Focus on Chondrosarcoma: A Twenty-year Study with a Focus on Surgical Treatment Outcomes
ANDRÉ S. ALVES, ADRIANO FABI and CARLO M. ORANGES

Anticancer Research October 2025, 45 (10) 4535-4546; DOI: https://doi.org/10.21873/anticanres.17800
You have access
Heterogeneous c-Met Activation in Osteosarcoma Dictates Synergistic Vulnerability to Combined c-Met Inhibition and Methotrexate Therapy
GUIDONG LI, HIROYUKI KAWASHIMA, TARO SASAKI, TAKASHI ARIIZUMI, NAOKI OIKE and AKIRA OGOSE

Anticancer Research July 2025, 45 (7) 2791-2806; DOI: https://doi.org/10.21873/anticanres.17648
You have access
Magnolol Suppresses Osteosarcoma Progression via Apoptosis Induction and EGFR/AKT Pathway Inactivation in a U-2 OS Xenograft Model
CHI-HUAN LI, CHIA-JUNG TSAI, FEI-TING HSU, BING-RU PENG, MAO-CHI WENG, TSAI-LAN LIAO, HSIAO-CHIA WANG, CHING-YU HAN and JIANN-HWA CHEN

Anticancer Research July 2025, 45 (7) 2949-2961; DOI: https://doi.org/10.21873/anticanres.17662
Open Access
Super Methotrexate-resistant Osteosarcoma Cells Retain Their Sensitivity to Recombinant Methioninase: Targeting Methionine Addiction to Overcome Extreme Cancer-Chemotherapy Resistance
YUSUKE AOKI, QINGHONG HAN, YUTARO KUBOTA, NORIYUKI MASAKI, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research March 2025, 45 (3) 929-934; DOI: https://doi.org/10.21873/anticanres.17480
Open Access
Highly Synergistic Eradication of 143B Osteosarcoma Cells In Vitro by the Combination of Recombinant Methioninase, Chloroquine, and Rapamycin Targeting Methionine Addiction, Autophagy, and mTOR, Respectively
SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN

Anticancer Research March 2025, 45 (3) 935-941; DOI: https://doi.org/10.21873/anticanres.17481

Main menu

User menu

Search

osteosarcoma

Pages